InSite Vision Incorporated - Product Pipeline Review - 2015

Published: Jun, 2015 | Pages: 40 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

InSite Vision Incorporated - Product Pipeline Review - 2015

Summary

Global Markets Direct's, 'InSite Vision Incorporated - Product Pipeline Review - 2015', provides an overview of the InSite Vision Incorporated's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of InSite Vision Incorporated's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of InSite Vision Incorporated including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of InSite Vision Incorporated's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the InSite Vision Incorporated's pipeline products

Reasons to buy

- Evaluate InSite Vision Incorporated's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of InSite Vision Incorporated in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the InSite Vision Incorporated's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of InSite Vision Incorporated and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of InSite Vision Incorporated
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
- Explore the dormant and discontinued projects of InSite Vision Incorporated and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
InSite Vision Incorporated Snapshot 5
InSite Vision Incorporated Overview 5
Key Information 5
Key Facts 5
InSite Vision Incorporated - Research and Development Overview 6
Key Therapeutic Areas 6
InSite Vision Incorporated - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Combination Treatment Modalities 10
InSite Vision Incorporated - Pipeline Products Glance 11
InSite Vision Incorporated - Late Stage Pipeline Products 11
Phase III Products/Combination Treatment Modalities 11
InSite Vision Incorporated - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
InSite Vision Incorporated - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Discovery Products/Combination Treatment Modalities 14
InSite Vision Incorporated - Drug Profiles 15
dexamethasone acetate 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
ISV-303 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
ISV-101 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
bimatoprost 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
ISV-405 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
ketorolac tromethamine 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
tetracycline 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
(bromfenac sodium + dexamethasone acetate) 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
InSite Vision Incorporated - Pipeline Analysis 24
InSite Vision Incorporated - Pipeline Products by Target 24
InSite Vision Incorporated - Pipeline Products by Route of Administration 25
InSite Vision Incorporated - Pipeline Products by Molecule Type 26
InSite Vision Incorporated - Pipeline Products by Mechanism of Action 27
InSite Vision Incorporated - Recent Pipeline Updates 28
InSite Vision Incorporated - Dormant Projects 33
InSite Vision Incorporated - Discontinued Pipeline Products 34
Discontinued Pipeline Product Profiles 34
ISV-208 34
InSite Vision Incorporated - Company Statement 35
InSite Vision Incorporated - Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Appendix 39
Methodology 39
Coverage 39
Secondary Research 39
Primary Research 39
Expert Panel Validation 39
Contact Us 39
Disclaimer 40

List of Tables

InSite Vision Incorporated, Key Information 5
InSite Vision Incorporated, Key Facts 5
InSite Vision Incorporated - Pipeline by Indication, 2015 7
InSite Vision Incorporated - Pipeline by Stage of Development, 2015 8
InSite Vision Incorporated - Monotherapy Products in Pipeline, 2015 9
InSite Vision Incorporated - Combination Treatment Modalities in Pipeline, 2015 10
InSite Vision Incorporated - Phase III, 2015 11
InSite Vision Incorporated - Phase II, 2015 12
InSite Vision Incorporated - Preclinical, 2015 13
InSite Vision Incorporated - Discovery, 2015 14
InSite Vision Incorporated - Pipeline by Target, 2015 24
InSite Vision Incorporated - Pipeline by Route of Administration, 2015 25
InSite Vision Incorporated - Pipeline by Molecule Type, 2015 26
InSite Vision Incorporated - Pipeline Products by Mechanism of Action, 2015 27
InSite Vision Incorporated - Recent Pipeline Updates, 2015 28
InSite Vision Incorporated - Dormant Developmental Projects,2015 33
InSite Vision Incorporated - Discontinued Pipeline Products, 2015 34
InSite Vision Incorporated, Subsidiaries 38